Total Funding
83
59
Total FundingSeries B raised
Growth Score
-4 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
55014
Organoid Sciences is an organoid-based treatment drug development company that offers drug screening and regenerative medicines.
- KyungJin Lee: Chief Technology Officer and co-founder
- Sang Hoon Oh: CEO & Executive Representative Director
About the Company
Organoid Sciences is a biotechnology company that develops organoid-based regenerative therapies, precision medicine platforms, and drug evaluation solutions. The company uses patient-derived organoids and adult stem cell technologies to model human biology, support personalized treatment, and reduce reliance on animal testing. Its core platforms
include ATORM for organoid regenerative therapeutics, ODISEI for organoid-based drug and material evaluation, and PODOTX for immuno-oncology sensitivity testing. The company also provides CDMO services and research-use organoid products for pharmaceutical and biotech partners.
